Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer

Citation
Rh. Hruban et al., Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer, DIGEST DIS, 19(1), 2001, pp. 76-84
Citations number
72
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
DIGESTIVE DISEASES
ISSN journal
02572753 → ACNP
Volume
19
Issue
1
Year of publication
2001
Pages
76 - 84
Database
ISI
SICI code
0257-2753(2001)19:1<76:POPCAS>2.0.ZU;2-I
Abstract
At the current time, pancreatic cancer remains a difficult and typically fa tal disease. A number of case reports and case-control epidemiologic studie s have suggested that familial aggregation plays a role in as many as 10% o f all pancreatic cancers. During the last several years, genetic alteration s responsible for syndromes linked with pancreatic cancer have been identif ied. These genes include BRCA2, p16, PRSS1, STK11, and various mismatch rep air genes. Unfortunately, most kindreds with a familiar aggregation cannot be explained by one of these known genetic syndromes. Recent data from the National Familial Pancreas Tumor Registry at Johns Hopkins have estimated t he prospective risk of pancreatic cancer among first-degree relatives of pa ncreatic cancer patients. The risk was estimated by comparing observed new cases of pancreatic cancer to expected numbers. In families where three fir st-degree relatives had been diagnosed with pancreatic cancer, the risk of another individual developing pancreatic cancer rose to a 57-fold increase over the basal risk. This article reviews the data concerning familial panc reatic cancer. Additionally, this article reviews the data concerning the h istological precursors of invasive ductal adenocarcinoma of the pancreas: p ancreatic intraepithelial neoplasias. Further, the current Johns Hopkins me thodology used to screen for early pancreatic neoplasia in familial pancrea tic cancer patients and in patients with familial Peutz-Jeghers syndrome is discussed. In summary, the notable advances in the field of molecular gene tics have allowed for a better definition of the genetics of pancreatic can cer. With this knowledge has evolved a better understanding of several high -risk clinical syndromes associated with pancreatic cancer, familial pancre atic cancer, and the evolution of strategies to screen high-risk families f or early pancreatic neoplasia. Copyright (C) 2001 S. Karger AG, Basel.